The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Drug: sandostatin     Quarter: 2016Q3

Total Records: 2,045     Number of Pages: 103

DRUGNAME PT EventCount
SANDOSTATIN LAR DEPOT Blood cortisol decreased 8
SANDOSTATIN LAR DEPOT Breath sounds abnormal 8
SANDOSTATIN LAR DEPOT Cardiac disorder 8
SANDOSTATIN LAR DEPOT Cholecystitis 8
SANDOSTATIN LAR DEPOT Clostridium difficile infection 8
SANDOSTATIN LAR DEPOT Dementia Alzheimer's type 8
SANDOSTATIN LAR DEPOT Device related infection 8
SANDOSTATIN LAR DEPOT Dizziness postural 8
SANDOSTATIN LAR DEPOT Emotional disorder 8
SANDOSTATIN LAR DEPOT Eye movement disorder 8
SANDOSTATIN LAR DEPOT Gastrointestinal infection 8
SANDOSTATIN LAR DEPOT Gastrointestinal sounds abnormal 8
SANDOSTATIN LAR DEPOT Glaucoma 8
SANDOSTATIN LAR DEPOT Glucose tolerance impaired 8
SANDOSTATIN LAR DEPOT Glycosylated haemoglobin increased 8
SANDOSTATIN LAR DEPOT Haemangioma 8
SANDOSTATIN LAR DEPOT Haematoma 8
SANDOSTATIN LAR DEPOT Herpes zoster 8
SANDOSTATIN LAR DEPOT Hypoacusis 8
SANDOSTATIN LAR DEPOT Injection site pruritus 8

Total Records: 2,045     Number of Pages: 103